Navigation Links
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
Date:11/13/2007

of the webcast will be available on Isis' web site for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing drugs for a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding the development, activity, therapeutic potential and safety of mipomersen in treating patients with high cholesterol. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement, including those statements that are described as Isis' goals. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products. Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  China Nepstar Chain Drugstore ... leading retail drugstore chain in China ... today announced the resignation of Mr. Fuxiang Zhang ... reasons, effective immediately. Ms. Rebecca Yingnan Zhang ... Company,s board of directors, effective immediately. Meanwhile, Ms. Zhang ...
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
(Date:5/21/2015)... NEW YORK , 21. Mai ... (NASDAQ: DPRX ), ein Unternehmen ... sich auf die Entwicklung und Vermarktung ... Forschungszusammenarbeit konzentriert, kündigte heute eine wissenschaftliche ... der Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... 15, 2011 "Blueprint to Quit" is a ... smokers interested in quitting, available exclusively at Walmart. ... behavioral support resources on QuitNet.com – including trained ... self-assessment tools – and nicotine replacement therapy (NRT) ...
... Biosciences, Inc., a company focused on novel immunotherapy biologic ... today announced financial results for the third quarter ended ... cash equivalents as of September 30, 2011 were approximately ... $29.6 million for the nine month period ended September ...
Cached Medicine Technology:New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 2New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 3New "Blueprint to Quit" Comprehensive Smoking Cessation Program Available for Smokers 4Coronado Biosciences Reports Third Quarter 2011 Financial Results 2Coronado Biosciences Reports Third Quarter 2011 Financial Results 3Coronado Biosciences Reports Third Quarter 2011 Financial Results 4Coronado Biosciences Reports Third Quarter 2011 Financial Results 5
(Date:5/22/2015)... Washington, DC (PRWEB) May 22, 2015 ... Howard University Hospital’s world-renowned surgical oncologist, Dr. LaSalle D. ... celebration. , The luncheon began after Grand Rounds in ... Delores Leffall, waited anxiously outside the auditorium, trying to ... hear him, but if he sees me, he’ll know ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to a ... all generations are equally as likely to worry about what ... 75% Gen X, 77% Boomers, 69% Silent Generation), which may ... they are scared of aging, particularly Millennials (47%), Gen X’ers ... Harris Poll in April, 2015 among more than 2,000 U.S. ...
(Date:5/22/2015)... May 22, 2015 According to Berks ... for drug related death, totaling almost 2,500 confirmed drug deaths, ... by state officials, totals 2,489 deaths stemming from legal and ... Pennsylvania loses seven people every day to fatal overdoses or ... singled out as one of the most rife with drug ...
(Date:5/22/2015)... VA (PRWEB) May 22, 2015 sweetFrog Enterprises, ... location in Jacksonville, Texas. Jacksonville is now the 16th sweetFrog ... yogurt chain was listed as #22 on the Inc. 500 ... “I have lived and worked in East Texas for 20 ... Brad Anderson, owner of the Jacksonville, and nearby Palestine, sweetFrog ...
(Date:5/22/2015)... Ticket Down is a reputable source for ... Eastern Conference Finals Tickets . All seating for the ... the ticket listing. , For the first time in ... of the Eastern Conference. One of the original franchises in ... and downs over the years, but the excitement level for ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... announced that they have created a computer tool ... microbicides// used by women for preventing HIV infections. ... infections globally are soaring. ,By applying ... a computer model that can predict the effectiveness ...
... Research Hospital have discovered that a protein called ABCB6 plays ... key to the ability// of red blood cells to carry ... cells to extract energy from nutrients. ,The St. ... membrane of the cell’s energy powerhouse called the mitochondria; and ...
... on par with other children from single births for ... has been found wanting and they fared less better ... twins receive less attention from parents as well as ... of 11,000 youngsters shows that twins are catching up. ...
... the good news: Suicide rates among younger and older Americans ... news: No one really knows why// . ,Those ... the University of South Carolina and released Thursday (Sept. 28) ... Health. ,Dr. Robert McKeown, a professor and associate ...
... by scientists at the Broad Institute of MIT and Harvard ... “roadmap” that can connect human diseases// with potential drugs to ... in human cells. Called the 'Connectivity Map,' the new tool ... of Science and in separate publications in the September 28 ...
... faculty members performing microsurgery in Tanzania from a computer ... experts// in Vietnam presenting an avian influenza patient to ... are some of the possible applications of a high-tech ... first time next week to link Johns Hopkins faculty ...
Cached Medicine News:Health News:Computer Tool Predicts Effectiveness Of Microbicides 2Health News:Computer Tool Predicts Effectiveness Of Microbicides 3Health News:ABCB6 Is Key to Production of Heme in Hemoglobin 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 2Health News:Most Suicide Rates Decline, but Findings Are Puzzling 3Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 2Health News:Genetic 'Roadmap' Charts Links Between Drugs and Human Disease 3Health News:High-Speed Internet2 Link Revolutionizes Global Medical Education 2
... and CVA for CELL-DYN are assayed linearity ... calibration and to verify patient reportable range ... kits also measure the linear performance of ... kits have customized ranges appropriate for each ...
... is a nucleated red blood cell (nRBC) control ... Coulter LH 750/LH 755 hematology analyzer in its ... for the Coulter LH 750/LH 755. nRBC-Chex for ... cap-pierceable vials. nRBC-Chex for LH has a 75-day ...
... negative whole blood control to test for ... tests and hemoglobin electrophoresis. Sickle-Chex is compatible ... solubility kits. Sickle-Chex is packaged in a ... dispenses an accurate sample volume. No pipeting ...
... Proprietary EX.P.R.T. Release Technology ... No stent shortening,, Unique anatomically designed ... the carotid bifurcation,, 0.014 Rapid Exchange ... profile and flexible atraumatic tip,, Radiopaque ...
Medicine Products: